Rachel Weinerman, MD
Clinical Assistant Professor, Obstetrics and Gynecology, CWRU School of Medicine
UH Fertility Center
1000 Auburn Rd
UH Ahjua Medical Center, Kathy Risman Pavilion, Ste 310
Reproductive Endocrinology and Infertility, Polycystic Ovary Syndrome (PCOS), Infertility, Minimally Invasive Surgery, Intrauterine Insemination, Fertility Preservation, Recurrent Pregnancy Loss, Same-Sex Couples, Gynecology, Amenorrhea, Menstrual Cycle Issues, In Vitro Fertilization, Ovulation Induction
American Board of Obstetrics and Gynecology - Obstetrics and Gynecology
American Board of Obstetrics and Gynecology - Reproductive Endocrinology/Infertility
Education & Training
2003, Harvard University
Medical / Professional School(s):
2008, Harvard Medical School
2012, Obstetrics and Gynecology - New York University School of Medicine and Langone Medical Center
2015, Reproductive Endocrinology - University of Pennsylvania School of Medicine
Awards & Recognition
2015 Luigi Mastroianni Research Award, Philadelphia Area Reproductive Endocrine Society
2015 Society for Reproductive Endocrinology Prize Paper Award, American Society for Reproductive Medicine Annual Meeting, Baltimore, MD
2014 Research grant from the Foundation for the Assessment and Enhancement of Embryonic Competence
2014 Society of Reproductive Biologists Award for oral presentation at the American Society for Reproductive Medicine Annual Meeting, Honolulu, HI
2013 National Research Service Institutional Training Award (T32), University of Pennsylvania
In-vitro fertilization perinatal outcomes, Embryo selection, Embryo vitrification
Patient Satisfaction Reviews
About Our Survey
At University Hospitals, we believe in providing patients with all the information they need to make educated decisions about their health care and to choose the right doctor to meet their needs. That is why we partner with the independent patient satisfaction company Press Ganey to survey patients about their experiences at UH facilities and with UH physicians. We hold ourselves to the highest standards of care and are dedicated to creating a positive patient experience for every individual who sees a UH doctor.
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2015, Rachel Weinerman, MD disclosed the following Outside Relationships with Industry:
Sermonix Pharmaceuticals - "Stock, stock options or other ownership interests"
Sermonix Pharmaceuticals - Ownership